SGLT2 Inhibitors in Type 2 Diabetes: Cardiorenal Protection Mechanisms and Clinical Outcomes
2026 | NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES (NIJSES) | Pp. 131-134
Type 2 diabetes mellitus was a complex metabolic disorder associated with a high burden of cardiovascular and renal complications, which remained the leading causes of morbidity and mortality despite advances in glycemic control strategies. Sodium glucose cot...